MD
MDT
Quarter ended Apr 26, 2024 · FY2024 Q4

Medtronic (MDT) Revenue — Quarter Ended Apr 26, 2024

Revenue rose in the current quarter, increasing sequentially from the prior quarter and also improving compared to the same period a year ago. The quarterly performance reflects a continued upward trajectory.

Key takeaway

Quarter ended Apr 26, 2024 · FY2024 Q4

Revenue rose in the current quarter, increasing sequentially from the prior quarter and also improving compared to the same period a year ago. The quarterly performance reflects a continued upward trajectory.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$8.6B

Revenue reported for this quarter.

Quarter-over-quarter

+6.2%

Change from the immediately preceding quarter.

Year-over-year

+0.5%

Change from the comparable year-ago quarter.

Trailing four quarters

$32.4B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Jul 28, 2023$7.7B+4.5%
Oct 27, 2023$8B+5.3%
Jan 26, 2024$8.1B+4.7%
Apr 26, 2024$8.6B+0.5%

Revenue performance

Revenue growth accelerated on a sequential basis, while the year-over-year gain was more moderate. This indicates stronger near-term momentum relative to the longer-term trend.

Quarterly comparison

Compared to the immediately preceding quarter, revenue posted a solid sequential increase. Versus the same quarter one year earlier, the advance was more restrained but still positive.

What to watch

Monitor whether revenue growth can sustain its sequential acceleration in the coming quarters.

Medtronic (MDT) Revenue — Quarter Ended Apr 26, 2024